Sfoglia per AUTORE
HASSANALI A
Collezione AO Ordine Mauriziano
Items : 2
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial. in The lancet. Gastroenterology & hepatology / Lancet Gastroenterol Hepatol. 2023 Jan;8(1):43-55. doi: 10.1016/S2468-1253(22)00303-X. Epub 2022 Oct
2023
AO Ordine Mauriziano
AO Ordine Mauriziano
Rydzewska G; Panaccione R; Baía C; Atreya R; Laharie D; Valentine JF; Jacob-Moffatt R; Eden C; Daperno M; Hassanali A; Sharafali Z; Danese S; Sandborn WJ; Panés J; Aguilar H; Vermeire S;
Impact of various central endoscopy reading models on treatment outcome in Crohn's disease using data from the randomized, controlled, exploratory cohort arm of the BERGAMOT trial. in Gastrointestinal endoscopy / Gastrointest Endosc. 2021 Jan;93(1):174-182.e2. doi: 10.1016/j.gie.2020.05.020. Epub 2020 May 25.
2021
AO Ordine Mauriziano
AO Ordine Mauriziano
Jacob R; Hussain F; Schreiber S; Oh YS; Mishkin DS; Reinisch W; Hassanali A; Daperno M;